JPRN-UMIN000001321招募中未知
The study of Immucyst for the prophylaxis of the superficial bladder cancer at a intermediate risk for the intravesical recurrence - IMAX
Department of Urology, Tokyo Women's Medical University0 个研究点目标入组 200 人开始时间: 2008年8月20日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) The history or the presence of Invasive bladder cancer with T2 or more 2) untreated CIS 3) single tumor of Ta, G1 4) tumor of T1,G3 5) associated malignant tumors at the upper urinary tract and/or the urethra 6) the presence of metastases to the lymph nodes and/or the distant organ or active double cancer 7) The presence of active tuberculosis infection with or without the anti-tuberculosis therapy 8) Contraindication for BCG instillation therapy
研究者
相似试验
进行中（未招募）
不适用
Secondary prophylaxis of invasive mycosis in immunocompromised patients by means of a weekly high dose of liposomal Amphotericin B - NDInvasive fungal infection in immunocompromised patientsMedDRA version: 8.1Level: LLTClassification code 10052366Term: Systemic mycosisEUCTR2006-005030-20-ITISTITUTO GIANNINA GASLINI
已完成
不适用
A Study of the Prevention of Alloimmunisation using Leukocyte-Depleted Red Cell and Platelet DonationsCancerISRCTN43344383Pall Biomedical Ltd (UK)
已完成
不适用
Pilot study on immune modulatory activity of a pre-probiotic blend in healthy adult volunteersfood allergyNL-OMON45397utricia Research30
进行中（未招募）
1 期
Primary prevention of type 1 diabetes in young children at high risk for type 1 diabetes using intranasal insuliRisk for type 1 diabetesEUCTR2015-003379-31-DETechnische Universität München, Fakultät für Medizin38
招募中
不适用
Development of a new immunotherapy using intramuscular administration of autologous total IgGNeoplasmsKCT0003258Ajou University Hospital30